FindTrial
Sign In

A comparative study of exosomal protein markers in ovarian cancer and normal human ovarian tissues

A comparative study of exosomal protein markers in ovarian cancer and normal human ovarian tissues

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053817
Enrollment
Unknown
Registered
2021-11-30
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Healthy people group:None
Ovarian cancer group:None

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. All patients received gynecological examination and MRI/CT/PET-CT examination before operation; 2. All signed the informed consent form related to this research; 3. Patients with ovarian cancer confirmed by pathology; 4. Staging according to FIGO criteria.

Exclusion criteria

Exclusion criteria: 1. Combined with malignant tumors other than ovarian cancer; 2. Pathologically confirmed distant metastasis; 3. Combined and cognitive dysfunction; 4. Those with a history of drug abuse or drug abuse.

Design outcomes

Primary

MeasureTime frame
Exosomal protein;—

Countries

China

Contacts

Public ContactChang Lei

The First Affiliated Hospital of Zhengzhou University

nancy.lei7985@hotmail.com+86 18538277078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026